RHB Group Research

Broker's Calls

RHB lowers forecasts for Bumitama Agri despite in-line 9MFY2022 results

RHB's Singapore research team says it sees the agri company “closing in on a record year”.

Broker's Calls

First Resources' 9MFY2022 earnings 'strongly above expectations', RHB raises TP to $1.75

The analysts raised their earnings forecasts by 8%-23% for FY2022-FY2024.

Broker's Calls

With strong balance sheet, IREIT’s gearing 'among the lowest' for S-REITs, but RHB trims TP

With 37 assets across Europe, IREIT has no debts maturing until November 2026.
Singtel's special dividend sweetens 1HFY2023 results - THE EDGE SINGAPORE

Broker's Calls

Singtel's special dividend sweetens 1HFY2023 results

Singtel's special dividend is payable in two tranches: December 2022 and August 2023.
RHB upgrades Golden Agri-Resources to 'buy' with higher TP of 33 cents - THE EDGE SINGAPORE

Broker's Calls

RHB upgrades Golden Agri-Resources to 'buy' with higher TP of 33 cents

Golden Agri’s 9MFY2022 core net profit of US$683 million exceeded expectations at 103% of the analysts’ full-year forecasts
Palm oil stock levels to remain high until year end, RHB maintains 'neutral' - THE EDGE SINGAPORE

Broker's Calls

Palm oil stock levels to remain high until year end, RHB maintains 'neutral'

Given the recent price increase, the tax levy in Indonesia may be reapplied sooner than expected.

Broker's Calls

Analysts maintain “buy” on Prime US REIT, but cut target prices

The analysts believe that the REIT is oversold, having lost almost 50% of its share price since the start of the year.
Manulife US REIT begins 'hotelisation', considers diversifying into other asset classes - THE EDGE SINGAPORE

REITs

Manulife US REIT begins 'hotelisation', considers diversifying into other asset classes

“We’re taking a look at all of our options. If we continue doing the same things, we’re going to get the same results.”
RHB maintains 'buy' on ComfortDelGro with higher TP of $1.80 amid new contract wins  - THE EDGE SINGAPORE

Broker's Calls

RHB maintains 'buy' on ComfortDelGro with higher TP of $1.80 amid new contract wins

The analyst believes that CDG should continue to witness gradual earnings recovery.
×